April 30, 2018 / 2:38 PM / 3 months ago

BRIEF-Karo Pharma Determines Terms For Rights Issue

April 30 (Reuters) - Karo Pharma AB:

* THE TERMS FOR KARO PHARMA’S RIGHTS ISSUE HAVE BEEN DETERMINED

* FOR EACH EXISTING SHARE HELD AT RECORD DATE, SHAREHOLDERS WILL RECEIVE ONE (1) SUBSCRIPTION RIGHT

* SUBSCRIPTION PRICE HAS BEEN SET AT SEK 24.00 PER SHARE

* RIGHTS ISSUE WILL AT MOST RAISE SEK 1,314.7 MILLION BEFORE ISSUE COSTS

* ISSUANCE OF A MAXIMUM OF 54,777,594 NEW ORDINARY SHARES

* TWO (2) SUBSCRIPTION RIGHTS ENTITLING HOLDER TO SUBSCRIBE FOR ONE (1) ORDINARY NEW SHARE (I.E. A SUBSCRIPTION RATIO OF 1:2)

* SUBSCRIPTION PERIOD WILL RUN BETWEEN 14 MAY 2018 UNTIL 29 MAY 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below